Accueil
Ken Fantom
Ken Fantom
Affiliations
R&D Platform Technology & Science , GlaxoSmithKline , Gunnels Wood Road , Stevenage SG1 2NY , United Kingdom.
Publications (2)
Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib.
The Journal of pharmacology and experimental therapeutics
Avec:
M Begg
,
R Wilson
,
J N Hamblin
,
M Montembault
,
J Green
,
A Deans
,
A Amour
,
S Worsley
,
K Fantom
,
Y Cui
,
G Dear
,
S Ahmad
,
A Kielkowska
,
J Clark
,
M Boyce
,
A Cahn
,
E M Hessel
Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.
Journal of the American Chemical Society
Avec:
Henrik Johansson
,
Yi-Chun Isabella Tsai
,
Ken Fantom
,
Chun-Wa Chung
,
Sandra Kümper
,
Luigi Martino
,
Daniel A Thomas
,
H Christian Eberl
,
Marcel Muelbaier
,
David House
,
Katrin Rittinger
Réseau de co-auteurs
M Begg
1 collaboration
R Wilson
1 collaboration
J N Hamblin
1 collaboration
M Montembault
1 collaboration
J Green
1 collaboration
A Deans
1 collaboration
A Amour
1 collaboration
S Worsley
1 collaboration
K Fantom
1 collaboration
Y Cui
1 collaboration
G Dear
1 collaboration
S Ahmad
1 collaboration
A Kielkowska
1 collaboration
J Clark
1 collaboration
M Boyce
1 collaboration
A Cahn
1 collaboration
E M Hessel
1 collaboration
Henrik Johansson
1 collaboration
Yi-Chun Isabella Tsai
1 collaboration
Chun-Wa Chung
1 collaboration
Sandra Kümper
1 collaboration
Luigi Martino
1 collaboration
Daniel A Thomas
1 collaboration
H Christian Eberl
1 collaboration
Marcel Muelbaier
1 collaboration
David House
1 collaboration
Katrin Rittinger
1 collaboration